The global Central Nervous System Biomarkers market is projected to grow from US$ 4216.2 million in 2024 to US$ 5946.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.

Central Nervous System Biomarkers Market

With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological conditions.

Market Analysis and Insights: Global Central Nervous System Biomarkers Market

The US & Canada market for Central Nervous System Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Central Nervous System Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Central Nervous System Biomarkers is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Central Nervous System Biomarkers include Merck, Takeda Pharmaceutical, Thermo Fisher Scientific, Avacta Group, Diagenic Asa, Banyan Biomarkers, Eli Lilly, Pfizer and Alseres Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Central Nervous System Biomarkers is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Central Nervous System Biomarkers industry development. In 2023, global % revenue of Central Nervous System Biomarkers went into Hospitals filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Central Nervous System Biomarkers market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Central Nervous System Biomarkers, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Central Nervous System Biomarkers, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Central Nervous System Biomarkers revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Central Nervous System Biomarkers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Central Nervous System Biomarkers revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Central Nervous System Biomarkers Market Report

Report Metric	Details
Report Name	Central Nervous System Biomarkers Market
Accounted market size in 2024	US$ 4216.2 million
Forecasted market size in 2030	US$ 5946.9 million
CAGR	5.9
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Safety Biomarker Efficacy Biomarker Validation Biomarker Other
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Takeda Pharmaceutical, Thermo Fisher Scientific, Avacta Group, Diagenic Asa, Banyan Biomarkers, Eli Lilly, Pfizer, Alseres Pharmaceuticals, Acumen pharmaceuticals, EKF Diagnostics, Abiant, Myriad RBM, Aposense
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Central Nervous System Biomarkers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System Biomarkers companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Central Nervous System Biomarkers revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Central Nervous System Biomarkers Market growing?

Ans: The Central Nervous System Biomarkers Market witnessing a CAGR of 5.9 during the forecast period 2025-2030.

What is the Central Nervous System Biomarkers Market size in 2030?

Ans: The Central Nervous System Biomarkers Market size in 2030 will be US$ 5946.9 million.

Who are the main players in the Central Nervous System Biomarkers Market report?

Ans: The main players in the Central Nervous System Biomarkers Market are Merck, Takeda Pharmaceutical, Thermo Fisher Scientific, Avacta Group, Diagenic Asa, Banyan Biomarkers, Eli Lilly, Pfizer, Alseres Pharmaceuticals, Acumen pharmaceuticals, EKF Diagnostics, Abiant, Myriad RBM, Aposense

What are the Application segmentation covered in the Central Nervous System Biomarkers Market report?

Ans: The Applications covered in the Central Nervous System Biomarkers Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Central Nervous System Biomarkers Market report?

Ans: The Types covered in the Central Nervous System Biomarkers Market report are Safety Biomarker, Efficacy Biomarker, Validation Biomarker, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Central Nervous System Biomarkers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Safety Biomarker

1.2.3 Efficacy Biomarker

1.2.4 Validation Biomarker

1.2.5 Other

1.3 Market by Application

1.3.1 Global Central Nervous System Biomarkers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Central Nervous System Biomarkers Market Perspective (2019-2030)

2.2 Global Central Nervous System Biomarkers Growth Trends by Region

2.2.1 Central Nervous System Biomarkers Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Central Nervous System Biomarkers Historic Market Size by Region (2019-2024)

2.2.3 Central Nervous System Biomarkers Forecasted Market Size by Region (2025-2030)

2.3 Central Nervous System Biomarkers Market Dynamics

2.3.1 Central Nervous System Biomarkers Industry Trends

2.3.2 Central Nervous System Biomarkers Market Drivers

2.3.3 Central Nervous System Biomarkers Market Challenges

2.3.4 Central Nervous System Biomarkers Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Central Nervous System Biomarkers by Players

3.1.1 Global Central Nervous System Biomarkers Revenue by Players (2019-2024)

3.1.2 Global Central Nervous System Biomarkers Revenue Market Share by Players (2019-2024)

3.2 Global Central Nervous System Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Central Nervous System Biomarkers, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Central Nervous System Biomarkers Market Concentration Ratio

3.4.1 Global Central Nervous System Biomarkers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System Biomarkers Revenue in 2023

3.5 Global Key Players of Central Nervous System Biomarkers Head office and Area Served

3.6 Global Key Players of Central Nervous System Biomarkers, Product and Application

3.7 Global Key Players of Central Nervous System Biomarkers, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System Biomarkers Breakdown Data by Type

4.1 Global Central Nervous System Biomarkers Historic Market Size by Type (2019-2024)

4.2 Global Central Nervous System Biomarkers Forecasted Market Size by Type (2025-2030)

5 Central Nervous System Biomarkers Breakdown Data by Application

5.1 Global Central Nervous System Biomarkers Historic Market Size by Application (2019-2024)

5.2 Global Central Nervous System Biomarkers Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Central Nervous System Biomarkers Market Size (2019-2030)

6.2 North America Central Nervous System Biomarkers Market Size by Type

6.2.1 North America Central Nervous System Biomarkers Market Size by Type (2019-2024)

6.2.2 North America Central Nervous System Biomarkers Market Size by Type (2025-2030)

6.2.3 North America Central Nervous System Biomarkers Market Share by Type (2019-2030)

6.3 North America Central Nervous System Biomarkers Market Size by Application

6.3.1 North America Central Nervous System Biomarkers Market Size by Application (2019-2024)

6.3.2 North America Central Nervous System Biomarkers Market Size by Application (2025-2030)

6.3.3 North America Central Nervous System Biomarkers Market Share by Application (2019-2030)

6.4 North America Central Nervous System Biomarkers Market Size by Country

6.4.1 North America Central Nervous System Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Central Nervous System Biomarkers Market Size by Country (2019-2024)

6.4.3 North America Central Nervous System Biomarkers Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Central Nervous System Biomarkers Market Size (2019-2030)

7.2 Europe Central Nervous System Biomarkers Market Size by Type

7.2.1 Europe Central Nervous System Biomarkers Market Size by Type (2019-2024)

7.2.2 Europe Central Nervous System Biomarkers Market Size by Type (2025-2030)

7.2.3 Europe Central Nervous System Biomarkers Market Share by Type (2019-2030)

7.3 Europe Central Nervous System Biomarkers Market Size by Application

7.3.1 Europe Central Nervous System Biomarkers Market Size by Application (2019-2024)

7.3.2 Europe Central Nervous System Biomarkers Market Size by Application (2025-2030)

7.3.3 Europe Central Nervous System Biomarkers Market Share by Application (2019-2030)

7.4 Europe Central Nervous System Biomarkers Market Size by Country

7.4.1 Europe Central Nervous System Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Central Nervous System Biomarkers Market Size by Country (2019-2024)

7.4.3 Europe Central Nervous System Biomarkers Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Central Nervous System Biomarkers Market Size (2019-2030)

8.2 China Central Nervous System Biomarkers Market Size by Type

8.2.1 China Central Nervous System Biomarkers Market Size by Type (2019-2024)

8.2.2 China Central Nervous System Biomarkers Market Size by Type (2025-2030)

8.2.3 China Central Nervous System Biomarkers Market Share by Type (2019-2030)

8.3 China Central Nervous System Biomarkers Market Size by Application

8.3.1 China Central Nervous System Biomarkers Market Size by Application (2019-2024)

8.3.2 China Central Nervous System Biomarkers Market Size by Application (2025-2030)

8.3.3 China Central Nervous System Biomarkers Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Central Nervous System Biomarkers Market Size (2019-2030)

9.2 Asia Central Nervous System Biomarkers Market Size by Type

9.2.1 Asia Central Nervous System Biomarkers Market Size by Type (2019-2024)

9.2.2 Asia Central Nervous System Biomarkers Market Size by Type (2025-2030)

9.2.3 Asia Central Nervous System Biomarkers Market Share by Type (2019-2030)

9.3 Asia Central Nervous System Biomarkers Market Size by Application

9.3.1 Asia Central Nervous System Biomarkers Market Size by Application (2019-2024)

9.3.2 Asia Central Nervous System Biomarkers Market Size by Application (2025-2030)

9.3.3 Asia Central Nervous System Biomarkers Market Share by Application (2019-2030)

9.4 Asia Central Nervous System Biomarkers Market Size by Region

9.4.1 Asia Central Nervous System Biomarkers Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Central Nervous System Biomarkers Market Size by Region (2019-2024)

9.4.3 Asia Central Nervous System Biomarkers Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Type

10.2.1 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Application

10.3.1 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Country

10.4.1 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Central Nervous System Biomarkers Introduction

11.1.4 Merck Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.1.5 Merck Recent Developments

11.2 Takeda Pharmaceutical

11.2.1 Takeda Pharmaceutical Company Details

11.2.2 Takeda Pharmaceutical Business Overview

11.2.3 Takeda Pharmaceutical Central Nervous System Biomarkers Introduction

11.2.4 Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.2.5 Takeda Pharmaceutical Recent Developments

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Central Nervous System Biomarkers Introduction

11.3.4 Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.3.5 Thermo Fisher Scientific Recent Developments

11.4 Avacta Group

11.4.1 Avacta Group Company Details

11.4.2 Avacta Group Business Overview

11.4.3 Avacta Group Central Nervous System Biomarkers Introduction

11.4.4 Avacta Group Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.4.5 Avacta Group Recent Developments

11.5 Diagenic Asa

11.5.1 Diagenic Asa Company Details

11.5.2 Diagenic Asa Business Overview

11.5.3 Diagenic Asa Central Nervous System Biomarkers Introduction

11.5.4 Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.5.5 Diagenic Asa Recent Developments

11.6 Banyan Biomarkers

11.6.1 Banyan Biomarkers Company Details

11.6.2 Banyan Biomarkers Business Overview

11.6.3 Banyan Biomarkers Central Nervous System Biomarkers Introduction

11.6.4 Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.6.5 Banyan Biomarkers Recent Developments

11.7 Eli Lilly

11.7.1 Eli Lilly Company Details

11.7.2 Eli Lilly Business Overview

11.7.3 Eli Lilly Central Nervous System Biomarkers Introduction

11.7.4 Eli Lilly Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.7.5 Eli Lilly Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Central Nervous System Biomarkers Introduction

11.8.4 Pfizer Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.8.5 Pfizer Recent Developments

11.9 Alseres Pharmaceuticals

11.9.1 Alseres Pharmaceuticals Company Details

11.9.2 Alseres Pharmaceuticals Business Overview

11.9.3 Alseres Pharmaceuticals Central Nervous System Biomarkers Introduction

11.9.4 Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.9.5 Alseres Pharmaceuticals Recent Developments

11.10 Acumen pharmaceuticals

11.10.1 Acumen pharmaceuticals Company Details

11.10.2 Acumen pharmaceuticals Business Overview

11.10.3 Acumen pharmaceuticals Central Nervous System Biomarkers Introduction

11.10.4 Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.10.5 Acumen pharmaceuticals Recent Developments

11.11 EKF Diagnostics

11.11.1 EKF Diagnostics Company Details

11.11.2 EKF Diagnostics Business Overview

11.11.3 EKF Diagnostics Central Nervous System Biomarkers Introduction

11.11.4 EKF Diagnostics Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.11.5 EKF Diagnostics Recent Developments

11.12 Abiant

11.12.1 Abiant Company Details

11.12.2 Abiant Business Overview

11.12.3 Abiant Central Nervous System Biomarkers Introduction

11.12.4 Abiant Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.12.5 Abiant Recent Developments

11.13 Myriad RBM

11.13.1 Myriad RBM Company Details

11.13.2 Myriad RBM Business Overview

11.13.3 Myriad RBM Central Nervous System Biomarkers Introduction

11.13.4 Myriad RBM Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.13.5 Myriad RBM Recent Developments

11.14 Aposense

11.14.1 Aposense Company Details

11.14.2 Aposense Business Overview

11.14.3 Aposense Central Nervous System Biomarkers Introduction

11.14.4 Aposense Revenue in Central Nervous System Biomarkers Business (2019-2024)

11.14.5 Aposense Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Merck

Takeda Pharmaceutical

Thermo Fisher Scientific

Alseres Pharmaceuticals

Acumen pharmaceuticals

List of Tables

Table 1. Global Central Nervous System Biomarkers Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Safety Biomarker

Table 3. Key Players of Efficacy Biomarker

Table 4. Key Players of Validation Biomarker

Table 5. Key Players of Other

Table 6. Global Central Nervous System Biomarkers Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Central Nervous System Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Central Nervous System Biomarkers Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Central Nervous System Biomarkers Market Share by Region (2019-2024)

Table 10. Global Central Nervous System Biomarkers Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Central Nervous System Biomarkers Market Share by Region (2025-2030)

Table 12. Central Nervous System Biomarkers Market Trends

Table 13. Central Nervous System Biomarkers Market Drivers

Table 14. Central Nervous System Biomarkers Market Challenges

Table 15. Central Nervous System Biomarkers Market Restraints

Table 16. Global Central Nervous System Biomarkers Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Central Nervous System Biomarkers Revenue Share by Players (2019-2024)

Table 18. Global Top Central Nervous System Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarkers as of 2023)

Table 19. Global Central Nervous System Biomarkers Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Central Nervous System Biomarkers Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Central Nervous System Biomarkers, Headquarters and Area Served

Table 22. Global Key Players of Central Nervous System Biomarkers, Product and Application

Table 23. Global Key Players of Central Nervous System Biomarkers, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Central Nervous System Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Central Nervous System Biomarkers Revenue Market Share by Type (2019-2024)

Table 27. Global Central Nervous System Biomarkers Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Central Nervous System Biomarkers Revenue Market Share by Type (2025-2030)

Table 29. Global Central Nervous System Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Central Nervous System Biomarkers Revenue Share by Application (2019-2024)

Table 31. Global Central Nervous System Biomarkers Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Central Nervous System Biomarkers Revenue Share by Application (2025-2030)

Table 33. North America Central Nervous System Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Central Nervous System Biomarkers Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Central Nervous System Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Central Nervous System Biomarkers Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Central Nervous System Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Central Nervous System Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Central Nervous System Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Central Nervous System Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Central Nervous System Biomarkers Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Central Nervous System Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Central Nervous System Biomarkers Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Central Nervous System Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Central Nervous System Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Central Nervous System Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Central Nervous System Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Central Nervous System Biomarkers Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Central Nervous System Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Central Nervous System Biomarkers Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Central Nervous System Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Central Nervous System Biomarkers Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Central Nervous System Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Central Nervous System Biomarkers Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Central Nervous System Biomarkers Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Central Nervous System Biomarkers Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Central Nervous System Biomarkers Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Central Nervous System Biomarkers Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 65. Merck Company Details

Table 66. Merck Business Overview

Table 67. Merck Central Nervous System Biomarkers Product

Table 68. Merck Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 69. Merck Recent Developments

Table 70. Takeda Pharmaceutical Company Details

Table 71. Takeda Pharmaceutical Business Overview

Table 72. Takeda Pharmaceutical Central Nervous System Biomarkers Product

Table 73. Takeda Pharmaceutical Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 74. Takeda Pharmaceutical Recent Developments

Table 75. Thermo Fisher Scientific Company Details

Table 76. Thermo Fisher Scientific Business Overview

Table 77. Thermo Fisher Scientific Central Nervous System Biomarkers Product

Table 78. Thermo Fisher Scientific Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 79. Thermo Fisher Scientific Recent Developments

Table 80. Avacta Group Company Details

Table 81. Avacta Group Business Overview

Table 82. Avacta Group Central Nervous System Biomarkers Product

Table 83. Avacta Group Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 84. Avacta Group Recent Developments

Table 85. Diagenic Asa Company Details

Table 86. Diagenic Asa Business Overview

Table 87. Diagenic Asa Central Nervous System Biomarkers Product

Table 88. Diagenic Asa Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 89. Diagenic Asa Recent Developments

Table 90. Banyan Biomarkers Company Details

Table 91. Banyan Biomarkers Business Overview

Table 92. Banyan Biomarkers Central Nervous System Biomarkers Product

Table 93. Banyan Biomarkers Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 94. Banyan Biomarkers Recent Developments

Table 95. Eli Lilly Company Details

Table 96. Eli Lilly Business Overview

Table 97. Eli Lilly Central Nervous System Biomarkers Product

Table 98. Eli Lilly Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 99. Eli Lilly Recent Developments

Table 100. Pfizer Company Details

Table 101. Pfizer Business Overview

Table 102. Pfizer Central Nervous System Biomarkers Product

Table 103. Pfizer Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 104. Pfizer Recent Developments

Table 105. Alseres Pharmaceuticals Company Details

Table 106. Alseres Pharmaceuticals Business Overview

Table 107. Alseres Pharmaceuticals Central Nervous System Biomarkers Product

Table 108. Alseres Pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 109. Alseres Pharmaceuticals Recent Developments

Table 110. Acumen pharmaceuticals Company Details

Table 111. Acumen pharmaceuticals Business Overview

Table 112. Acumen pharmaceuticals Central Nervous System Biomarkers Product

Table 113. Acumen pharmaceuticals Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 114. Acumen pharmaceuticals Recent Developments

Table 115. EKF Diagnostics Company Details

Table 116. EKF Diagnostics Business Overview

Table 117. EKF Diagnostics Central Nervous System Biomarkers Product

Table 118. EKF Diagnostics Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 119. EKF Diagnostics Recent Developments

Table 120. Abiant Company Details

Table 121. Abiant Business Overview

Table 122. Abiant Central Nervous System Biomarkers Product

Table 123. Abiant Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 124. Abiant Recent Developments

Table 125. Myriad RBM Company Details

Table 126. Myriad RBM Business Overview

Table 127. Myriad RBM Central Nervous System Biomarkers Product

Table 128. Myriad RBM Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 129. Myriad RBM Recent Developments

Table 130. Aposense Company Details

Table 131. Aposense Business Overview

Table 132. Aposense Central Nervous System Biomarkers Product

Table 133. Aposense Revenue in Central Nervous System Biomarkers Business (2019-2024) & (US$ Million)

Table 134. Aposense Recent Developments

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Central Nervous System Biomarkers Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Central Nervous System Biomarkers Market Share by Type: 2023 VS 2030

Figure 3. Safety Biomarker Features

Figure 4. Efficacy Biomarker Features

Figure 5. Validation Biomarker Features

Figure 6. Other Features

Figure 7. Global Central Nervous System Biomarkers Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Central Nervous System Biomarkers Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Central Nervous System Biomarkers Report Years Considered

Figure 13. Global Central Nervous System Biomarkers Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Central Nervous System Biomarkers Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Central Nervous System Biomarkers Market Share by Region: 2023 VS 2030

Figure 16. Global Central Nervous System Biomarkers Market Share by Players in 2023

Figure 17. Global Top Central Nervous System Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System Biomarkers as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Central Nervous System Biomarkers Revenue in 2023

Figure 19. North America Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Central Nervous System Biomarkers Market Share by Type (2019-2030)

Figure 21. North America Central Nervous System Biomarkers Market Share by Application (2019-2030)

Figure 22. North America Central Nervous System Biomarkers Market Share by Country (2019-2030)

Figure 23. United States Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Central Nervous System Biomarkers Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Central Nervous System Biomarkers Market Share by Type (2019-2030)

Figure 27. Europe Central Nervous System Biomarkers Market Share by Application (2019-2030)

Figure 28. Europe Central Nervous System Biomarkers Market Share by Country (2019-2030)

Figure 29. Germany Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Central Nervous System Biomarkers Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Central Nervous System Biomarkers Market Share by Type (2019-2030)

Figure 37. China Central Nervous System Biomarkers Market Share by Application (2019-2030)

Figure 38. Asia Central Nervous System Biomarkers Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Central Nervous System Biomarkers Market Share by Type (2019-2030)

Figure 40. Asia Central Nervous System Biomarkers Market Share by Application (2019-2030)

Figure 41. Asia Central Nervous System Biomarkers Market Share by Region (2019-2030)

Figure 42. Japan Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Central Nervous System Biomarkers Market Share by Country (2019-2030)

Figure 52. Brazil Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Central Nervous System Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Merck Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 59. Takeda Pharmaceutical Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 61. Avacta Group Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 62. Diagenic Asa Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 63. Banyan Biomarkers Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 64. Eli Lilly Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 65. Pfizer Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 66. Alseres Pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 67. Acumen pharmaceuticals Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 68. EKF Diagnostics Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 69. Abiant Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 70. Myriad RBM Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 71. Aposense Revenue Growth Rate in Central Nervous System Biomarkers Business (2019-2024)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions